Searched for
SANJAY MURDESHWAR MD ASTRAZENECA PHARMA INDIA
SplitSena? At least 6 UBT Lok Sabha MPs planning to meet SpeakerShiv Sena UBT is on the brink of another split. At least six Lok Sabha MPs are preparing to form a separate group. Maharashtra Deputy CM Ek...- Raakh true story explained: Everything you need to know about the chilling Ranga-Billa case. How did it change actor Bobby Deol's childhood?Prime Video's Raakh brings the 1978 Ranga-Billa case to light. The crime drama is inspired by the kidnapping and murder of Delhi siblings G...
- CAG asks states to disclose off-budget borrowings in A/CsIndia's Comptroller and Auditor General, K Sanjay Murthy, urged state governments to fully disclose their off-budget borrowings. He highlig...
- Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
- Light at the end of the tunnel? Gautam Shah sees Nifty eyeing 25,500, bets on smallcaps, pharma and Adani stocksIndian equities are nearing a crucial turning point, with market veteran Gautam Shah suggesting a shift in focus beyond benchmark indices. ...
- Former Tech Mahindra executive Rajashree R joins VC firm Kalaari CapitalFormer Tech Mahindra executive Rajashree R has joined venture capital firm Kalaari Capital, bringing nearly two decades of IT sector experi...
- Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gearsIndia's electronics sector is poised for significant growth, potentially becoming a manufacturing and export powerhouse. Free Trade Agreeme...
- RBI Governor meets Bengal CM Adhikari ahead of state's first budgetReserve Bank of India Governor Sanjay Malhotra met West Bengal Chief Minister Suvendu Adhikari in Kolkata. They discussed key economic issu...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Duty relief may be extended for petrochemical inputs for pharmaRavi Teja, deputy director at the Department of Commerce, told reporters in Hyderabad on Tuesday that a review is underway for a possible e...
- India a major growth market for Celonis, says senior execThe Germany-based company said it already serves 260 global capability centres (GCCs) in India, counting companies such as Mercedes-Benz, H...
- Keenly watching India-US trade deal developments: Brown-Forman India MDBrown-Forman, the maker of Jack Daniel's, is closely monitoring the India-United States trade deal. Positive signs are emerging for the bil...
- SBI Chairman, Apple India MD among 29 members appointed to Board of TradeThe government has appointed 29 non-official members to the Board of Trade. This includes prominent figures like SBI Chairman CS Setty and ...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...
Load More
